CELC INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
Kirby McInerney LLP announced it is investigating potential securities fraud claims against Celcuity Inc., concerning whether the company violated federal securities laws. The investigation references a recent press release regarding FDA approval for therapy Revtorpyk, where analysts noted a delayed commercial launch timeline that preceded a 17.6% stock drop.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.